Patents by Inventor Roman Kamburg

Roman Kamburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080227838
    Abstract: A method for prevention, inhibition or treatment of neuronal degeneration caused by injury, disease, disorder or condition in the central nervous system (CNS) comprises administering a glycoluril derivative to an individual in need thereof.
    Type: Application
    Filed: March 15, 2007
    Publication date: September 18, 2008
    Applicant: Cereprotec Incorporated
    Inventor: Roman Kamburg
  • Publication number: 20050191359
    Abstract: Hydrophilic dispersions of stable nano-sized particles are provided comprising: (a) a water-insoluble or water-soluble active compound, wherein said active compound is selected from the group consisting of a macrolide antibiotic, donepezil hydrochloride, an azole compound and a taxane; and (b) an amphiphilic polymer which wraps said active compound in a non-crystalline manner to form a nano-sized molecular entity in which no valent bonds are formed.
    Type: Application
    Filed: September 29, 2004
    Publication date: September 1, 2005
    Applicant: SoluBest Ltd.
    Inventors: Rina Goldshtein, Roman Kamburg, Galina Ratner, Michael Kopylov, Ilya Zelkind, Vadim Goldshtein, Olga Skylarsky, Boris Tulbovich, Erwin Stern
  • Patent number: 6605638
    Abstract: The invention relates to the use of branched chain fatty acids (BFAs) and their derivatives for inhibition of the activity of P-glycoprotein (P-gp). In particular, the invention relates to the use of BFAs and their derivatives in the treatment of multi-drug resistant (MDR) tumors associated with increased activity of P-glycoprotein. The invention also relates to the use of the above-mentioned molecules for administration of biologically active molecules and diagnostic agents into cells associated with increased activity of P-gp, and for increasing accumulation of biologically active molecules and diagnostic agents in organs protected by biological barriers.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: August 12, 2003
    Assignee: D-Pharm Limited
    Inventors: Alexander Kozak, Roman Kamburg
  • Patent number: 4571403
    Abstract: The anginal medicated compound according to the present invention comprises the active principle 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo-/3,3,0/-octanedione-3,7 of the formula: ##STR1## in combination with a pharmaceutical carrier. The medicated compound according to the present invention is useful for the treatment of patients suffering from ischemic heart disease.
    Type: Grant
    Filed: December 6, 1984
    Date of Patent: February 18, 1986
    Assignee: Institut Organicheskoi Khimii Imeni N.D. Zelinskogo Akademii Nauk SSSR
    Inventors: Irina E. Zimakova, Dania A. Valimukhametova, Irina V. Zaikonnikova, Vladimir F. Bogoyavlensky, Natalya V. Kaverina, Roman A. Kamburg, Anatoly M. Karpov, Lenor I. Khmelnitsky, Oleg V. Lebedev, Lia V. Epishina, Lidia V. Lapshina, Ljudmila I. Suvorova, Nikolai V. Darinsky, Sergei S. Novikov, deceased